Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleReview
Open Access

S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence

MICHELE SCIALPI, EUGENIO MARTORANA, PIETRO SCIALPI, GIOVANNI BATTISTA SCALERA, EUGENIO BELATTI, MARIA CRISTINA AISA, ALFREDO D’ANDREA, FRANCESCO MARIA MANCIOLI, ALESSANDRO DI MARZO, FABIO TRIPPA and ALDO DI BLASI
Anticancer Research January 2023, 43 (1) 297-303; DOI: https://doi.org/10.21873/anticanres.16163
MICHELE SCIALPI
1Division of Diagnostic Imaging, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michelescialpi1{at}gmail.com
EUGENIO MARTORANA
2Division of Urology, Nuovo Ospedale Civile Sassuolo, Modena, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PIETRO SCIALPI
3Division of Urology, Portogruaro Hospital, Venice, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIOVANNI BATTISTA SCALERA
1Division of Diagnostic Imaging, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUGENIO BELATTI
1Division of Diagnostic Imaging, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA CRISTINA AISA
4Division of Obstetrics and Gynaecology, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALFREDO D’ANDREA
5Division of Radiology, Ospedale di Caserta, Caserta, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCESCO MARIA MANCIOLI
6Division of Radiology, Ospedale Santa Maria, Terni, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALESSANDRO DI MARZO
7Radiation Oncology Centre, Ospedale Santa Maria, Terni, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FABIO TRIPPA
7Radiation Oncology Centre, Ospedale Santa Maria, Terni, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALDO DI BLASI
8Division of Radiology, Tivoli Hospital, Tivoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Grayscale ADC map for quantitative analysis of the signal intensity (SI) of suspicious areas in S-PI-RADS and PI-RRADS. The apparent diffusion coefficient (ADC) scale measures the SI values of normal tissue and cell density of prostate cancer that increase with a decrease in ADC values. Three sub-parameters are identified: ADC minimum or ADCmin, ADC mean, and ADC maximum or ADCmax. ADCmax value is the water or urine (white) with high signal intensity value and is obtained from average of three circular regions-of-interest (ROIs) placed within the bladder; ADCmax value varies on the same MRI scanner and between different MRI scanners [for example on our 3T MRI unit (Achieva, Philips Medical Systems, Healthcare, Eindhoven, the Netherlands)] equipped with a phased array body coil, the ADCmax value on the ADC map generated using b-values of 0, 500, 1000 and 1500 s/mm2 can reach an average value of 4000]. ADCmin value is the bone (black) equal to 0 and is obtained from a circular ROI placed within the femur head; ADCmin value does not vary on the same MRI scanner nor between different MRI scanners. ADCmean is obtained from the formula: ADCmean=(ADCmax + ADCmin)/2. On grayscale ADC map, measurable and homogeneous areas with ADC values ≥ ADCmean can be considered as moderately hypointense SI areas on ADC map, while those with ADC values < ADCmean are considered as markedly hypointense SI areas on the ADC map.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (1)
Anticancer Research
Vol. 43, Issue 1
January 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence
MICHELE SCIALPI, EUGENIO MARTORANA, PIETRO SCIALPI, GIOVANNI BATTISTA SCALERA, EUGENIO BELATTI, MARIA CRISTINA AISA, ALFREDO D’ANDREA, FRANCESCO MARIA MANCIOLI, ALESSANDRO DI MARZO, FABIO TRIPPA, ALDO DI BLASI
Anticancer Research Jan 2023, 43 (1) 297-303; DOI: 10.21873/anticanres.16163

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence
MICHELE SCIALPI, EUGENIO MARTORANA, PIETRO SCIALPI, GIOVANNI BATTISTA SCALERA, EUGENIO BELATTI, MARIA CRISTINA AISA, ALFREDO D’ANDREA, FRANCESCO MARIA MANCIOLI, ALESSANDRO DI MARZO, FABIO TRIPPA, ALDO DI BLASI
Anticancer Research Jan 2023, 43 (1) 297-303; DOI: 10.21873/anticanres.16163
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Biparametric Prostate MRI Protocol in Diagnosis and Post-treatment of Prostate Cancer
    • Steps for Biparametric MR Images Reading and Interpretation
    • S-PI-RADS and PI-RRADS Categories bpMRI-based
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
  • Biparametric MRI for Local Staging of Prostate Cancer: Current Status and Future Applications
  • Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy
  • Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging
  • Google Scholar

More in this TOC Section

  • Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer
  • Inflammatory Cytokine Genotypic Markers and Ovarian Cancer Risk
  • Recurrence and Malignant Transformation After Borderline Ovarian Tumors: A Systematic Review and Meta-analysis
Show more Review

Keywords

  • Prostate cancer
  • recurrence
  • radiation therapy
  • radical prostatectomy
  • magnetic resonance imaging
  • simplified prostate magnetic resonance imaging for reporting (S-PI-RADS)
  • prostate magnetic resonance imaging for local recurrence reporting (PI-RRADS)
  • review
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire